Increasing evidence has shown that aberrant activation of tumor-associated signaling pathways in many different tumors can induce tumor cells proliferation, metastasis and epithelial-mesenchymal transition, such as Wnt/beta-catenin signaling, Hippo signaling and mTOR signaling 9-11. This evidence concerns the gene MTOR and neoplasm.